Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study

Código QR

Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study

Ibrahim Y Allam,1 Sihem Lazreg,2 Mohamed Shafik Shaheen,1 Mohamed Fahmy Doheim,1 Mai A Mohammed1 1Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt; 2Cabinet Ophtalmologie, Alger Centre, Algiers, AlgeriaCorrespondence: Ibrahim Y AllamOphthalmology Department, Fa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Allam IY, Lazreg S, Shafik Shaheen M, Doheim MF, Mohammed MA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	thyroid eye disease dry eye disease ocular surface thyroid antibodies Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/6faf677d9f13430e9ba723e85116e405
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY
por: V. G. Likhvantseva, et al.
Publicado: (2017)

Assessment of tear-evaporation rate in thyroid-gland patients
por: Abusharaha A, et al.
Publicado: (2019)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu E, et al.
Publicado: (2020)

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
por: Stonecipher KG, et al.
Publicado: (2016)

Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease
por: Nattis A, et al.
Publicado: (2019)

The proportion of ocular surface diseases in untreated patients with epiphora
por: Ishikawa S, et al.
Publicado: (2018)

Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
por: Atallah RT, et al.
Publicado: (2019)

High Prevalence of Abnormal Ocular Surface Tests in a Healthy Pediatric Population
por: Rojas-Carabali W, et al.
Publicado: (2020)

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
por: Silverstein S, et al.
Publicado: (2020)

An assessment of the ocular tear film in patients with thyroid disorders
por: Alanazi SA, et al.
Publicado: (2019)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018)

Patient-reported severity of dry eye and quality of life in diabetes
por: Yazdani-Ibn-Taz MK, et al.
Publicado: (2019)

Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City
por: Martinez JD, et al.
Publicado: (2016)

Risk of Refractive Prediction Error After Cataract Surgery in Patients with Thyroid Eye Disease
por: Strong Caldwell A, et al.
Publicado: (2021)

Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
por: Ebrahimiadib N, et al.
Publicado: (2020)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
por: White DE, et al.
Publicado: (2020)

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
por: White DE, et al.
Publicado: (2020)

Ocular manifestations in patients with systemic sclerosis
por: Małgorzata Kozikowska, et al.
Publicado: (2020)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
por: Groß D, et al.
Publicado: (2017)

Treatment of Dry Eye With Intracanalicular Injection of Hydroxybutyl Chitosan: A Prospective Randomized Clinical Trial
por: Tong Lin, et al.
Publicado: (2021)

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
por: Ryu KJ, et al.
Publicado: (2021)

Influence of diabetes mellitus on anterior segment of the eye
por: Han SB, et al.
Publicado: (2018)

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution
por: Favuzza E, et al.
Publicado: (2020)

Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study
por: Burillon C, et al.
Publicado: (2018)

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
por: Fogagnolo P, et al.
Publicado: (2020)

Stimulating Tear Production: Spotlight on Neurostimulation
por: Yu MD, et al.
Publicado: (2021)

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
por: McMullin D, et al.
Publicado: (2021)

A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease
por: Jerkins G, et al.
Publicado: (2020)

Thyroid research
Publicado: (2008)

Journal of thyroid research

Adaptación cultural y validación del cuestionario Ocular Surface Disease Index en una población chilena
por: Traipe,Leonidas, et al.
Publicado: (2020)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
por: Molina-Solana P, et al.
Publicado: (2020)

Making the diagnosis of Sjögren’s syndrome in patients with dry eye
por: Beckman KA, et al.
Publicado: (2015)

Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
por: Rathi SG, et al.
Publicado: (2018)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
por: Nasser L, et al.
Publicado: (2018)

A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease
por: Kuzmanović Elabjer B, et al.
Publicado: (2020)

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
por: Taylor M, et al.
Publicado: (2019)

Alta frecuencia de anticuerpos anti-tiroperoxidasa (ATPO) positivos en sujetos adultos, sin patología tiroidea conocida, de Santiago de Chile
por: LANAS,ALEJANDRA, et al.
Publicado: (2010)

Sex differences in the effect of aging on dry eye disease
por: Ahn JH, et al.
Publicado: (2017)

Non-Conventional Clinical Uses of TSH Receptor Antibodies: The Case of Chronic Autoimmune Thyroiditis
por: Giorgio Napolitano, et al.
Publicado: (2021)